I not think this good. Sadly Sales figures are pathetic and the cabazitaxel and docetaxel trials not likely to finish recruiting this CY so not expect there will be study completion until well into 2023 IMO.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report & Appendix 4C
I not think this good. Sadly Sales figures are pathetic and the...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.64M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.5¢ | $19.64K | 204.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 5390 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 0.095 |
2 | 305855 | 0.094 |
2 | 320000 | 0.093 |
1 | 100000 | 0.092 |
4 | 49861 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 5390 | 1 |
0.098 | 200000 | 1 |
0.100 | 106000 | 3 |
0.105 | 148467 | 3 |
0.110 | 183058 | 5 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |